Actively Recruiting
Non-Invasive Brain Stimulation to Improve Language in Down Syndrome.
Led by Floriana Costanzo · Updated on 2025-07-04
36
Participants Needed
1
Research Sites
61 weeks
Total Duration
On this page
Sponsors
F
Floriana Costanzo
Lead Sponsor
B
Bambino Gesù Children's Hospital IRCCS
Collaborating Sponsor
AI-Summary
What this Trial Is About
Down syndrome (DS) is associated with cognitive deficits, caused by alterations in neuroplasticity and synaptic transmission. Non-invasive brain stimulation techniques, such as transcranial direct current stimulation (tDCS), can modulate the brain's plasticity mechanisms and neurotransmitter balance. Anodal tDCS increases cortical excitability by depolarizing neurons, while cathodal tDCS decreases it through hyperpolarization. When combined with cognitive training, tDCS may produce faster and longer-lasting therapeutic effects. Although most of the neurorehabilitation studies have applied anodal excitatory stimulation, recent evidence suggests the potential cathodal inhibitory stimulation in neurodevelopmental disorders with alteration of synaptic transmission, as people with DS. Potentially both anodal and cathodal stimulation protocols could lead to positive clinical effects in DS. This proof-of-concept study is a double-blind, placebo-controlled, clinical trial aiming to evaluate the efficacy of two active tDCS protocols (anodal and cathodal) targeting the left inferior frontal gyrus (IFG) versus sham stimulation tDCS, combined with speech and language training, to improve language skills in adolescents and young adults with DS. The study also aims to identify the most effective parameters of tDCS treatment, for customization in adolescents and young adults with DS. Thirty-six participants, aged 12 to 21 years, will be randomly assigned to three groups receiving anodal, cathodal, or sham tDCS. Each participant will undergo 10 sessions of tDCS at 1 mA for 20 minutes, alongside speech and language training five times for two weeks. Neuropsychological, behavioral, biomarker (including brain-derived neurotrophic factor and neurofilament light chain), and electroencephalogram assessments will be performed at baseline, post-treatment, and three months after treatment completion. The study hypothesizes that tDCS will enhance language abilities, particularly expressive vocabulary, and modulate biomarkers of brain plasticity in DS participants. The study also hypothesizes that tDCS will enhance other cognitive and behavioral functions. Since tDCS effects may last, the study will check for improvements at the three-month. If effective, this combined approach of tDCS and language training could pave the way for new rehabilitation strategies for DS.
CONDITIONS
Official Title
Non-Invasive Brain Stimulation to Improve Language in Down Syndrome.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Italian speakers with confirmed free trisomy 21 (Down Syndrome) by genetic testing
- Aged between 12 and 21 years
- Mental age of 4 years or older as assessed by Leiter-3
- Scores below 2 standard deviations on the denomination subtest of BVL_4-12
- Speech intelligibility to close relatives with a score of at least 3.5 on the Intelligibility in Context Scale (ICS) Italian version
- Provided informed consent from the participant and their caregiver
You will not qualify if you...
- Presence of neurosensory deficits such as hearing loss or severe visual impairments
- History of epilepsy, family history of epilepsy, or major psychiatric disorders
- Scores below 10 points on the denomination subtest of BVL_4-12
- Difficulty verbally imitating fewer than 7 out of 10 words in a screening task
- Currently undergoing speech therapy or psychopharmacological treatment for cognitive or behavioral improvement
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Bambino Gesù Children's Hospital, IRCCS
Rome, Italy, Italy, 00165
Actively Recruiting
Research Team
F
Floriana Costanzo, PsyD, PhD
CONTACT
E
Elisa Fucà, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here